STAR0602

· Marengo Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STAR0602, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing